Conventional Lymphangiography (CL) in the Management of Postoperative Lymphatic Leakage (PLL): A Systematic Review

Author:

Sommer Christof M.1,Pieper Claus C.2,Itkin Maxim3,Nadolski Gregory J.3,Hur Saebeom4,Kim Jinoo5,Maleux Geert6,Kauczor Hans-Ulrich1,Richter Goetz M.7

Affiliation:

1. Clinic for Diagnostic and Interventional Radiology, University Hospital Heidelberg, Germany

2. Department of Radiology, University Hospital Bonn, Germany

3. Center for Lymphatic Imaging and Interventions, Hospital of the University of Philadelphia, Germany

4. Department of Radiology, Seoul National University Hospital, Seoul, Korea (the Republic of)

5. Department of Radiology, Ajou University Hospital, Suwon, Korea (the Republic of)

6. Department of Radiology, University Hospitals Leuven, Belgium

7. Clinic for Diagnostic and Interventional Radiology, Klinikum Stuttgart, Germany

Abstract

Background Postoperative lymphatic leakage (PLL) is usually managed by conservative and/or surgical treatments but these procedures can be challenging to perform and potentially clinically ineffective. Therefore, conventional lymphangiography (CL) has emerged as an important alternative. The aim of this review is to present the available outcome data on CL in the management of PLL.Method A systematic literature search (PubMed) using the MeSH term “lymphangiography” was performed and the search was restricted to literature published between January 2007 and August 2019. Identification, screening, and assessment for eligibility and inclusion were conducted in accordance with PRISMA.Results From the initially obtained 1006 articles (identification), 28 articles with a total of 201 patients were finally included (inclusion). The methodological quality of all included articles corresponds to level 4 (Oxford Centre for Evidence-based Medicine – Levels of Evidence, March 2009). PLL occurs after oncological and non-oncological surgery in the form of chylothorax, chylous ascites, and cervical, thoracic, abdominal and peripheral lymph fistula and/or lymphocele. The technical success rate of CL is 75–100 %. Access for CL is transpedal (176 patients) or intranodal (25 patients). Lipiodol is used as the contrast material in all articles, with a maximum amount of 20 ml for transpedal CL and 30 ml for intranodal CL. The X-ray imaging modalities used for CL are fluoroscopy, radiography and/or CT. Two articles report CL-associated major complications and CL-associated morbidity and mortality. The PLL cure rate is 51–70 % for transpedal CL (time to PLL cure: 2–29 days) and 33–100 % for intranodal CL (time to PLL cure: 2–< 30 days). Bailout procedures in the case of clinically ineffective CL include a range of treatments.Conclusion CL is feasible, safe, and effective in the management of PLL. Lipiodol as the contrast material is essential in CL because the highly viscous iodinated poppy-seed oil has not only diagnostic but therapeutic effects. Guidelines and randomized controlled trials are further steps towards defining the ultimate value of CL.Key Points: Citation Format

Publisher

Georg Thieme Verlag KG

Subject

Radiology Nuclear Medicine and imaging

Reference48 articles.

1. A review of the postoperative lymphatic leakage;S Lv;Oncotarget,2017

2. Percutaneous Treatment of Chylous Ascites;J Kim;Tech Vasc Interv Radiol,2016

3. Lymphatic Intervention for Various Types of Lymphorrhea: Access and Treatment;M Inoue;Radiogr Rev Publ Radiol Soc N Am Inc,2016

4. Chylous Ascites Management After Pancreatic Surgery;N Tabchouri;World J Surg,2017

5. Chylothorax: aetiology, diagnosis and therapeutic options;E E McGrath;Respir Med,2010

Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3